Source: Eur Respir J, 50 (5) 1700754; 10.1183/13993003.00754-2017
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrea Olschewski, Emma L. Veale, Bence M. Nagy, Chandran Nagaraj, Grazyna Kwapiszewska, Fabrice Antigny, Mélanie Lambert, Marc Humbert, Gábor Czirják, Péter Enyedi, Alistair Mathie. TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications. Eur Respir J, 50 (5) 1700754; 10.1183/13993003.00754-2017

Member's Comments

No comment yet.

Related content which might interest you: Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer (NSCLC) cells Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 TRPA1 ion channel expression in human lung myofibroblasts Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Identification of a TRPM7-like non-selective cation channel in human lung mast cells Source: Eur Respir J 2004; 24: Suppl. 48, 453s Year: 2004 The role of amiloride sensitive epithelial sodium channel (ENaC) in cell migration of mesothelioma cells is dependent on the cell type and the extracellular matrix Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 The role of aquaporin-1 (AQP1) and amiloride sensitive epithelial sodium (ENaC) in cell adhesion of mesothelioma cells is cell and extracellular matrix type dependent Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Regulation and population genetics of TRP channels Source: Research Sem. 13 Year: 2013 The chloride channel: pathology and specific therapy Source: International Congress 2015 – Cystic fibrosis: not just for the specialists Year: 2015 KCNK3 channel inactivation leads to pulmonary vascular alterations in rat Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Stem cells, lung pathogenesis and therapeutic potential Source: Annual Congress 2005 - Scientific year in review Year: 2005 ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020 Year: 2020 Genetic alteration in the mammalian chloride channel CLNS1A alter lung function in children Source: Eur Respir J 2006; 28: Suppl. 50, 476s Year: 2006 The cystic fibrosis transmembrane conductance regulator and its modulators: clinical implications Source: Virtual Congress 2020 – Respiratory infections Year: 2020 KCa3.1 ion channel is expressed by component cells of lymphangioleiomyomatosis (LAM) nodules Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 The pathophysiological roles of a voltage-gated potassium channel Kv1.5 in toluene diisocyanate-induced asthma Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002 The emerging role of transient receptor potential channels in chronic lung disease Source: Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016 Year: 2017 Ion channel modulation by adenosine in human lung mast cells Source: Eur Respir J 2005; 26: Suppl. 49, 225s Year: 2005 Inhibition of Ca2+-release activated Ca2+ channel (CRAC) and K+ channels of Jurkat T cell by curcumin Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010